Business Context and Reporting Period
Company: MIMEDX GROUP, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2013
Event: Unregistered Sales of Equity Securities (Item 3.02)
Key Financial Metrics
This filing reports a specific equity transaction rather than comprehensive financial performance metrics. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
- Shares Issued: 1,174,915 unregistered shares of common stock
- Transaction Value: Approximately $5,792,000
- Purpose: Earn-out consideration related to the acquisition of Surgical Biologics, LLC
Material Changes
The issuance of shares represents a material change in the company's capital structure. The consideration was calculated based on a formula tied to sales and certain expenses for the year ended December 31, 2012, regarding the Surgical Biologics, LLC acquisition.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the disclosure of the unregistered sale. It references Note 4 in the Company's Form 10-K filed on March 15, 2013, for further discussion of the contingent consideration.
Investor Verification Checklist
- Verify the exact formula used to calculate the earn-out consideration in the Form 10-K filed March 15, 2013.
- Confirm the impact of the 1,174,915 new shares on total outstanding share count and potential dilution.
- Review the financial performance of Surgical Biologics, LLC for the year ended December 31, 2012, to understand the basis for the $5,792,000 valuation.